Mereo BioPharma (MREO) Assets (2017 - 2026)
Mereo BioPharma (MREO) reported Assets of $34.71 million for Q2 2026, down 44.6% from $62.63 million a year earlier and down 14.5% from the prior quarter.
Powered by 
Analysis
Mereo BioPharma (MREO) Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Mereo BioPharma posted Assets of $45.92 million, down 39.9% from FY2024.
- Assets has a three-year compound annual growth rate of -16.0% (FY2022 to FY2025).
- By year, Assets came in at $76.39 million in FY2024 (+14.9%), $66.5 million in FY2023 (-14.1%) and $77.41 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Assets in data going back to Q4 2017.
- Year over year, Assets has now declined in each of the last five quarters, with an average decline of 23.2% over the last seven quarters.
- The high point for year-over-year Assets in five years was Q1 2025 (growth of 22.1%); the low point was Q2 2026 (a decline of 44.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $40.61 million (Q1 2026), $45.92 million (Q4 2025) and $53.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 119.92 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Mereo BioPharma | 47.91 Mn | -79.40 Mn | 800,000.00 | 29.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 29.58 Mn |
| Jun 30, 2026 | 34.71 Mn |
| Mar 31, 2026 | 40.61 Mn |
| Dec 31, 2025 | 45.92 Mn |
| Sep 30, 2025 | 53.60 Mn |
| Jun 30, 2025 | 62.63 Mn |
| Mar 31, 2025 | 68.32 Mn |
| Dec 31, 2024 | 76.39 Mn |
| Sep 30, 2024 | 88.75 Mn |
| Jun 30, 2024 | 96.13 Mn |
| Mar 31, 2024 | 55.94 Mn |
| Dec 31, 2023 | 66.50 Mn |
| Jun 30, 2023 | 101.72 Mn |
| Dec 31, 2022 | 103.31 Mn |
| Jun 30, 2022 | 131.07 Mn |
| Dec 31, 2021 | 170.64 Mn |
| Jun 30, 2021 | 200.60 Mn |
| Dec 31, 2020 | 85.80 Mn |
| Jun 30, 2020 | 135.15 Mn |
| Dec 31, 2019 | 113.36 Mn |
API Access
Mereo BioPharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=MREO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "MREO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=MREO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();